New York A 10211: Relates to extending the validity of drivers' licenses that expire between April 1, 2020 and July 1, 2020

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A10211 Summary:

BILL NOA10211 

&nbsp

SAME ASSAME AS S09496

&nbsp

SPONSORKelles

&nbsp

COSPNSRBurdick, Kay, Schiavoni, Simon, Levenberg

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L

&nbsp

Requires medicaid and insurers to include coverage for testing of PFAS levels in blood; defines PFAS.

Go to top A10211 Actions:

BILL NOA10211 

&nbsp

02/12/2026referred to insurance

Go to topA10211 Committee&nbspVotes:

Go to topA10211 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA10211 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 10211

 IN ASSEMBLY

 February 12, 2026
 ___________

 Introduced by M. of A. KELLES -- read once and referred to the Committee
 on Insurance

 AN ACT to amend the insurance law and the social services law, in
 relation to insurance coverage for testing for PFAS levels in blood

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subsection (i) of section 3216 of the insurance law is
 2 amended by adding a new paragraph 42 to read as follows:
 3 (42) (A) Every policy which provides medical, major medical, or simi-
 4 lar comprehensive-type coverage shall provide coverage for testing of
 5 PFAS levels in blood if ordered by a physician or other licensed health
 6 care provider legally authorized to order such testing under title eight
 7 of the education law.
 8 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl
 9 and polyfluoroalkyl substances.
 10 § 2. Subsection (k) of section 3221 of the insurance law is amended by
 11 adding a new paragraph 24 to read as follows:
 12 (24) (A) Every policy which provides medical, major medical, or simi-
 13 lar comprehensive-type coverage shall provide coverage for testing of
 14 PFAS levels in blood if ordered by a physician or other licensed health
 15 care provider legally authorized to order such testing under title eight
 16 of the education law.
 17 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl
 18 and polyfluoroalkyl substances.
 19 § 3. Section 4303 of the insurance law is amended by adding a new
 20 subsection (xx) to read as follows:
 21 (xx) (A) A medical expense indemnity corporation or a health service
 22 corporation which provides medical, major medical or similar comprehen-
 23 sive-type coverage shall include coverage for testing of PFAS levels in
 24 blood if ordered by a physician or other licensed health care provider
 25 legally authorized to order such testing under title eight of the educa-
 26 tion law.
 27 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl
 28 and polyfluoroalkyl substances.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD14314-01-5

 A. 10211 2

 1 § 4. Subdivision 2 of section 365-a of the social services law is
 2 amended by adding a new paragraph (oo) to read as follows:
 3 (oo) (i) (1) Medical assistance shall include testing of PFAS levels
 4 in blood if ordered by a physician or other licensed health care provid-
 5 er legally authorized to order such testing under title eight of the
 6 education law.
 7 (2) For the purposes of this paragraph, "PFAS" means perfluoroalkyl
 8 and polyfluoroalkyl substances.
 9 (ii) In the event that federal financial participation for such test-
 10 ing of PFAS in blood is not available, medical assistance shall not
 11 include coverage of these services.
 12 § 5. This act shall take effect the first of January next succeeding
 13 the date on which it shall have become a law and shall apply to all
 14 policies and contracts issued, renewed, modified, altered or amended on
 15 or after such effective date.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps